# Testosterone Replacement for Male Opioid Agonist Maintained Patients

> **NCT01873989** · PHASE1,PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 15 (actual)

## Conditions studied

- Chronic Pain
- Opioid Addiction
- Symptomatic Hypogonadism

## Interventions

- **DRUG:** Testosterone replacement
- **OTHER:** Waitlist control

## Key facts

- **NCT ID:** NCT01873989
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01873989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01873989, "Testosterone Replacement for Male Opioid Agonist Maintained Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01873989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*